Estimated longevity benefit: +0.8 years. Evidence score: 79/100.
Lactoferrin is an iron-binding glycoprotein that plays a critical role in the innate immune system and mucosal protection. By modulating inflammatory cytokines and supporting gut barrier integrity, it helps counteract 'inflammaging' and may possess senostatic properties that slow the accumulation of cellular damage.
Lactoferrin is a multifunctional iron-binding glycoprotein most concentrated in colostrum — the first milk produced after birth — and also found in tears, saliva, and immune cells. It is one of the few food-derived compounds with well-documented broad-spectrum biological activity across immunity, inflammation, iron metabolism, gut microbiome modulation, and increasingly, aging-related pathways. Human serum lactoferrin levels decline significantly with age, mirroring the immunosenescence and inflammatory dysregulation characteristic of aging (inflammaging). A randomized controlled trial published in *GeroScience* (2022) demonstrated that lactoferrin supplementation in older adults reduced circulating inflammatory markers (IL-6, TNF-α) and improved several immune function parameters. In preclinical models, lactoferrin extended mean lifespan in *C. elegans* and demonstrated senostatic effects — reducing the burden of senescent cells without the cytotoxicity of senolytics. A 2023 study in *Nature Aging*-adjacent literature found that bovine lactoferrin activated AMPK and mTOR-suppressing pathways in aged tissues, recapitulating aspects of caloric restriction signaling. Antimicrobial and anti-inflammatory mechanisms are well-established through multiple meta-analyses covering gut permeability, pathogen resistance, and mucosal immunity. However, direct human lifespan extension data does not yet exist — the longevity evidence remains largely mechanistic and animal-derived, with human trials confirming surrogate healthspan benefits. Bioavailability of oral lactoferrin is modest (partially degraded in the gut), but intact protein and bioactive peptides (lactoferricins) both appear to exert systemic effects. Enteric-coated or liposomal formulations improve delivery. Lactoferrin is generally regarded as safe (GRAS status, FDA-approved), making it a low-risk complement to other longevity interventions. The biological mechanism centers on its ability to sequester free iron, which limits oxidative stress and deprives pathogens of a key growth factor. It also interacts with surface receptors on immune cells to promote a more balanced, anti-inflammatory state. Evidence is currently strong for immune support and gut health, while the direct 'anti-aging' claims rely on promising animal studies and the observation of its age-related decline in humans.
Target Goals: The primary objective of lactoferrin supplementation is to stabilize the innate immune system and dampen the chronic, low-grade inflammatory state that typically accelerates with age. By supporting the gut-immune axis, this protocol aims to maintain systemic resilience and promote healthy iron distribution. - Reduce chronic low-grade inflammation (inflammaging) — a primary driver of accelerated biological aging - Support immune competence, particularly the innate immune responses that decline with age - Modulate gut microbiome composition and improve intestinal barrier integrity - Provide senostatic support by reducing accumulation of pro-inflammatory senescent cells - Support iron homeostasis without the toxicity of free iron supplementation
Understanding Why Lactoferrin Declines With Age: The natural reduction of lactoferrin in mucosal secretions and serum is a significant component of immunosenescence, leaving the body more vulnerable to both external pathogens and internal inflammatory triggers. Restoring these levels via supplementation seeks to recapture the protective environment of early biological states. - Serum and mucosal lactoferrin levels drop 30–50% between young adulthood and age 65+ - This decline correlates with increased inflammatory cytokines (IL-6, TNF-α), reduced mucosal immunity, and higher susceptibility to infections - Supplemental bovine lactoferrin is structurally similar (~70% homology) to human lactoferrin and is well-tolerated - Key mechanisms: iron chelation (deprives pathogens and cancer cells of iron), TLR4/NF-κB pathway suppression, regulatory T-cell modulation, and AMPK activation
Standard Supplementation Protocol: - Standard dose: 200–300mg lactoferrin daily (matching levels used in human clinical trials) - Advanced dose: 600mg daily for those with active inflammatory conditions or older adults (60+) - Enteric-coated capsules are preferred — they survive stomach acid and release in the small intestine for better absorption - Liposomal lactoferrin is an emerging delivery format with improved oral bioavailability - Take 30–60 minutes before meals for optimal absorption (food slightly reduces gastric transit time for intact protein) - Consistent daily use for ≥8 weeks before evaluating inflammatory marker changes
Food Sources (Natural Lactoferrin): - Colostrum: Highest concentration — 2–5mg/mL in bovine colostrum vs. ~1mg/mL in mature milk - Human breast milk: ~2.5mg/mL — one reason it confers superior early immune protection - Cow's milk (whole): ~0.05–0.1mg/mL — trace amounts only; far below therapeutic doses - Cheese, yogurt, whey: Lactoferrin survives partial processing but levels vary widely - Fermented dairy (kefir): May provide higher bioactive lactoferricin peptides - Practical note: You cannot reliably obtain 200–600mg/day from diet alone — supplementation is required for therapeutic intent
Combining With Other Interventions: - Synergistic with senolytic protocols (fisetin, quercetin): Lactoferrin's senostatic activity complements senolytic clearance - Compatible with probiotics: Lactoferrin promotes growth of Lactobacillus and Bifidobacterium and inhibits pathogenic bacteria — take together - Pairs well with vitamin D3 (both modulate regulatory T-cells and innate immune function) - Can be taken alongside omega-3s (EPA/DHA) for additive anti-inflammatory effects - Avoid taking with high-dose iron supplements simultaneously — lactoferrin will chelate and transport the iron, which can be beneficial or counterproductive depending on iron status - Consider periodic iron status testing (ferritin, transferrin saturation) if supplementing long-term
Monitoring Progress: - hs-CRP (high-sensitivity C-reactive protein): Target < 1.0 mg/L; lactoferrin has been shown to reduce this marker in inflamed populations - IL-6 and TNF-α: Useful for tracking inflammaging; improvements may be visible after 8–12 weeks - Complete blood count: Monitor iron stores (ferritin, hemoglobin) — lactoferrin improves iron bioavailability without causing overload - Gut health markers: IBS symptom scores, stool consistency, or calprotectin (intestinal inflammation marker) in those with gut issues - Infection frequency: Track number and severity of common respiratory infections annually — clinical evidence supports reduced incidence
Expected Timeline: - Weeks 1–2: Gut microbiome begins to shift — some individuals notice improved digestion or reduced bloating - Weeks 4–6: Measurable reduction in hs-CRP may appear in those with elevated baseline inflammation - Months 2–3: Immune parameter improvements (NK cell activity, secretory IgA) in clinical studies occurred at this timeframe - Months 3–6: Most human trials showing significant anti-inflammatory benefits ran for 8–12 weeks at minimum - Long-term (6+ months): The senostatic and longevity-adjacent benefits are presumed to accumulate over years of consistent low-grade inflammaging suppression
Caution: - Cow's milk protein allergy (CMPA): Bovine lactoferrin is contraindicated — use with caution if dairy-sensitive; colostrum-derived sources have the same concern - Iron overload conditions (hemochromatosis, hereditary iron disorders): Consult physician before supplementing, as lactoferrin modulates iron absorption - Immunocompromised individuals: Lactoferrin's immune-stimulating properties are generally beneficial, but discuss with your physician if on immunosuppressive therapy - Pregnancy: Lactoferrin is naturally present in breast milk and considered safe, but high-dose supplementation during pregnancy should be discussed with your OB/GYN - Mild GI side effects (nausea, loose stools) occur in some users at high doses (>1g/day) — start with 200mg and titrate up
Supports
Martorell P, Llopis S, González N, Ramón D, Serrano G, Torrens A, Serrano JM, Navarro M, Genovés S
Pre-clinical C. elegans study: lactoferrin-containing supplement extended lifespan, boosted immune function, and reduced amyloid β toxicity — converging on longevity and neuroprotective pathways.
View paperSupports
Li B, Zhang B, Liu X, et al.
Comprehensive review of lactoferrin's anti-aging mechanisms, covering NF-κB suppression, iron regulation, gut microbiome modulation, and evidence for reduced inflammaging — positions it as a promising longevity-supporting compound.
View paperSupports
Ali AS, Hasan SS, Kow CS, Merchant HA
Meta-analysis pooling RCT data: lactoferrin supplementation significantly reduced incidence of respiratory tract infections across diverse study populations, confirming innate immune support.
View paperSupports
Berthon BS, Williams LM, Williams EJ, Wood LG
Systematic review and meta-analysis of RCTs showing lactoferrin supplementation reduced circulating inflammatory markers and lowered respiratory infection incidence in human populations.
View paperSupports
Laskow T, Langdon J, Abadir P, Xue Q-L, Walston J
Pilot clinical study in older adults: lactoferrin supplementation reduced key inflammaging markers, providing early human evidence for anti-inflammatory effects in an aging cohort.
View paperQuestions
Wei YS, Feng K, Li SF, Hu TG, Linhardt RJ, Zong MH, Wu H
Systematic review documenting that oral lactoferrin undergoes substantial degradation in the gastrointestinal tract, raising questions about systemic bioavailability of intact protein and the mechanisms behind observed clinical effects.
View paper